Osteogenesis imperfecta (OI), also called brittle bone disease, rare hereditary disease of connective tissue characterized by brittle bones that fracture easily. OI arises from a genetic defect that causes abnormal or reduced production of the protein collagen, a major component of connective tissue. There are four types of OI, which differ in symptoms and severity.
Osteogenesis imperfecta is a disorder of connective tissue characterized by thin-walled, extremely fracture-prone bones deficient in osteoblasts (bone-forming cells), as well as by malformed teeth, blue sclerae, and progressive deafness. Type I osteogenesis imperfecta is the result of a dominant gene. It develops in childhood…
An infant with the most common type of OI, type I, is normal at birth, but fractures occur over the following years; the frequency of fractures tends to diminish after puberty. The sclerae of the eyes may appear bluish because of their abnormal thinness, which permits the pigmentation of the choroid (the middle coat of the eyeball) to show. Hearing loss may be caused by deformities of the bones of the inner ear as well as pressure on the auditory nerve because of deformity of its canal in the skull. Double-jointedness, brittle teeth, and abnormally thin skin are also characteristic of type I. In type II OI, the most severe form of the disease, stillbirth is common, or fractures are evident at birth; severe crippling often occurs, and survival to adulthood is uncommon. Type III OI causes symptoms that are similar to type I but is more severe. Type IV OI is moderately severe; it is also similar to type I, but the sclerae are normal.
There is no cure for OI; treatment is directed toward preventing fractures, controlling symptoms, and developing bone mass. Treatment with bisphosphonate drugs has proved effective in some patients, and the surgical insertion of metal rods in certain bones may prevent or correct deformities.